Adrian Kilcoyne - 03 Oct 2022 Form 4 Insider Report for Celularity Inc (CELU)

Role: Executive Vice President, Chief Medical Officer
Signature: /s/ Keary Dunn, Attorney-in-Fact
Issuer symbol: CELU
Transactions as of: 03 Oct 2022
Net transactions value: $0
Form type: 4
Filing time: 04 Oct 2022, 16:10:19 UTC
Previous filing: 04 Oct 2022
Next filing: 22 Feb 2023
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CELU	Stock Option (Right to Buy)	Award	$0	+66,226		$0.000000	66,226	03 Oct 2022	Class A Common Stock	66,226	$2.19	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This option was granted under the Issuer's 2021 Equity Incentive Plan. The shares underlying such option vest and become exercisable as follows: 25% on the one-year anniversary of the grant date, with the remainder vesting monthly thereafter so that it will be vested in full on the four-year anniversary of the grant date, subject to the Reporting Person's continuous service with the Issuer through each such date.

Content

This option was granted under the Issuer's 2021 Equity Incentive Plan. The shares underlying such option vest and become exercisable as follows: 25% on the one-year anniversary of the grant date, with the remainder vesting monthly thereafter so that it will be vested in full on the four-year anniversary of the grant date, subject to the Reporting Person's continuous service with the Issuer through each such date.

Remarks:

Executive Vice President, Chief Medical Officer